Authors:
NOWROUSIAN MR
WELT A
FOSSA A
KASPER C
SCHRODER J
KUHLMANN S
SCHUTTE J
KLOKE O
STUSCHKE M
SCHULEHEIN K
METZ KA
LEDER LD
SACK H
SEEBER S
Citation: Mr. Nowrousian et al., RESPONSE-ADAPTED SEQUENTIAL COMBINATION CHEMOTHERAPY (CEBOPP VIML) FOLLOWED BY RADIOTHERAPY FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE/, Annals of oncology, 9, 1998, pp. 514-514
Authors:
EBERHARDT W
WILKE H
STAMATIS G
STUSCHKE M
HARSTRICK A
MENKER H
KRAUSE B
MUELLER MR
STAHL M
FLASSHOVE M
BUDACH V
GRESCHUCHNA D
KONIETZKO N
SACK H
SEEBER S
Citation: W. Eberhardt et al., PREOPERATIVE CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIATION THERAPY BASED ON HYPERFRACTIONATED ACCELERATED RADIOTHERAPY AND DEFINITIVE SURGERY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER - MATURE RESULTS OF A PHASE-II TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 622-634
Authors:
STUBEN G
STUSCHKE M
KNUHMANN K
POTTGEN C
SACK H
Citation: G. Stuben et al., EXPERIMENTAL STUDIES ON THE POSSIBLE INFLUENCE OF INVASIVE OXYGEN MEASUREMENTS ON TUMOR RADIOSENSITIVITY, Acta oncologica, 37(4), 1998, pp. 369-373
Authors:
SACK H
HOEDERATH A
STUSCHKE M
BOHNDORF W
MAKOSKI HB
MULLER RP
POTTER R
Citation: H. Sack et al., RADIATION TREATMENT OF FOLLICLE CENTER LYMPHOMA - RESULTS OF A GERMANMULTICENTER AND PROSPECTIVE-STUDY, Strahlentherapie und Onkologie, 174(4), 1998, pp. 178-185
Citation: H. Sack, CATHETER-BASED RADIOTHERAPY TO INHIBIT RESTENOSIS AFTER CORONARY STENTING, Strahlentherapie und Onkologie, 174(3), 1998, pp. 168-168
Authors:
STUBEN G
STUSCHKE M
KNUHMANN K
HORSMAN MR
SACK H
Citation: G. Stuben et al., THE EFFECT OF COMBINED NICOTINAMIDE AND CARBOGEN TREATMENTS IN HUMAN TUMOR XENOGRAFTS - OXYGENATION AND TUMOR-CONTROL STUDIES, Radiotherapy and oncology, 48(2), 1998, pp. 143-148
Authors:
SCHRADER M
SCHIPPER J
JAHNKE K
STUSCHKE M
SACK H
BUDACH V
Citation: M. Schrader et al., HYPERFRACTIONATED-ACCELERATED SIMULTANEOU S RADIOCHEMOTHERAPY OF ADVANCED HYPOPHARYNGEAL CARCINOMAS - SURVIVAL RATES, FUNCTIONAL RESULTS AND QUALITY-OF-LIFE IN A PHASE-II STUDY, HNO. Hals-, Nasen-, Ohrenarzte, 46(2), 1998, pp. 140-145
Authors:
WELT A
ANHUF J
KRAWCZYK C
FOSSA A
STUSCHKE M
KLOKE O
SCHUTTE J
WESTERHAUSEN M
SACK H
SEEBER S
NOWROUSIAN MR
Citation: A. Welt et al., INITIAL HIGH-DOSE SEQUENTIAL CHEMOTHERAPY IN THE TREATMENT OF AGGRESSIVE NON-HODGKIN LYMPHOMAS WITH RISK-FACTORS, British Journal of Haematology, 102(1), 1998, pp. 237-237
Authors:
STUSCHKE M
SACK H
HOEDERATH A
POTTER R
MULLER RP
SCHULZ U
KARSTENS J
MAKOSKI HB
Citation: M. Stuschke et al., EXTENDED FIELD (EF) AND TOTAL CENTRAL LYMPHATIC (TCL) RADIOTHERAPY FOR EARLY STAGES NODAL CENTROBLASTIC-CENTROCYTIC (CB-CC) LYMPHOMAS, European journal of cancer, 33, 1997, pp. 1182-1182
Authors:
DINGES S
BUDACH V
STUSCHKE M
BUDACH W
BOEHMER D
SCHRADER M
JAHNKE K
SACK H
Citation: S. Dinges et al., CHEMORADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK-CANCER - LONG-TERM RESULTS OF A PHASE-II TRIAL, European journal of cancer, 33(7), 1997, pp. 1152-1155
Citation: W. Hiddemann et al., TREATMENT OF FOLLICULAR FOLLICLE CENTER LYMPHOMAS - CURRENT STATUS AND FUTURE PERSPECTIVES, Journal of internal medicine, 242, 1997, pp. 55-62
Authors:
STUBEN G
STUSCHKE M
KROLL M
HAVERS W
SACK H
Citation: G. Stuben et al., POSTOPERATIVE RADIOTHERAPY OF SPINAL AND INTRACRANIAL EPENDYMOMAS - ANALYSIS OF PROGNOSTIC FACTORS, Radiotherapy and oncology, 45(1), 1997, pp. 3-10
Authors:
KOCHER M
MULLER RP
ROSS D
HOEDERATH A
SACK H
Citation: M. Kocher et al., RADIOTHERAPY FOR TREATMENT OF LOCALIZED GASTROINTESTINAL NON-HODGKINS-LYMPHOMA (VOL 42, PG 37, 1997), Radiotherapy and oncology, 42(3), 1997, pp. 317-317
Authors:
BUDACH W
BUDACH V
DINGES S
STUSCHKE M
SACK H
Citation: W. Budach et al., CORRELATION BETWEEN PRIMARY CHEMO-SENSITIVITY AND RADIATION SENSITIVITY IN A PANEL OF HIGHLY MALIGNANT HUMAN SOFT-TISSUE SARCOMA XENOGRAFTS, Radiotherapy and oncology, 42(2), 1997, pp. 181-187
Authors:
KOCHER M
MULLER RP
ROSS D
HOEDERATH A
SACK H
Citation: M. Kocher et al., RADIOTHERAPY FOR TREATMENT OF LOCALIZED GASTROINTESTINAL NON-HODGKINS-LYMPHOMA, Radiotherapy and oncology, 42(1), 1997, pp. 37-41
Citation: W. Hiddemann et al., CURRENT STATUS OF THE THERAPEUTICS OF FOL LICLE CENTER LYMPHOMAS AND MANTLE CELL LYMPHOMAS, Der Internist, 38(2), 1997, pp. 122-134
Authors:
STUSCHKE M
HOEDERATH A
SACK H
POTTER R
MULLER RP
SCHULZ U
KARSTENS J
MAKOSKI HB
Citation: M. Stuschke et al., EXTENDED FIELD AND TOTAL CENTRAL LYMPHATIC RADIOTHERAPY IN THE TREATMENT OF EARLY-STAGE LYMPH-NODE CENTROBLASTIC-CENTROSYTIC LYMPHOMAS - RESULTS OF A PROSPECTIVE MULTICENTER STUDY, Cancer, 80(12), 1997, pp. 2273-2284
Authors:
STAHL M
WILKE H
FINK U
STUSCHKE M
WALZ MK
SIEWERT JR
MOLLS M
FETT W
MAKOSKI HB
BREUER N
SCHMIDT U
NIEBEL W
SACK H
EIGLER FW
SEEBER S
Citation: M. Stahl et al., COMBINED PREOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL CANCER - INTERIM ANALYSIS OF A PHASE-II TRIAL, Journal of clinical oncology, 14(3), 1996, pp. 829-837
Citation: P. Buschmann et al., MODELING PLASMALEMMA ION-TRANSPORT OF THE AQUATIC PLANT EGERIA-DENSA, The Journal of membrane biology, 154(2), 1996, pp. 109-118
Authors:
FARAHATI J
REINERS C
STUSCHKE M
MULLER SP
STUBEN G
SAUERWEIN W
SACK H
Citation: J. Farahati et al., DIFFERENTIATED THYROID-CANCER - IMPACT OF ADJUVANT EXTERNAL RADIOTHERAPY IN PATIENTS WITH PERITHYROIDAL TUMOR INFILTRATION (STAGE PT4), Cancer, 77(1), 1996, pp. 172-180
Authors:
DIEHL V
LOEFFLER M
PFREUNDSCHUH M
RUEHL U
HASENCLEVER D
NISTERSBACKES H
SIEBER M
SMITH K
TESCH H
GEILEN W
ADLER M
BARTELS H
BRANDENBURG U
DIEZLER P
DOELKEN G
ENZIAN J
FUCHS R
GASSMANN W
GERHARTZ H
HAGENAUKAMP U
HECHT T
HILLER E
HINKELBEIN H
LATHAN B
KIRCHNER H
KUEHN G
KUERTEN H
LOOS U
MAKOSKI B
OERTEL W
PETSCH S
PFAB R
PFLUEGER H
PLANKER M
ROHLOFF R
SACK H
SAMANDARI S
SAUER R
SCHALK K
SCHMITZ G
SCHOPPE W
SCHWIEDER G
SZEPESI S
TEICHMANN J
WILHELMY W
WORST P
FISCHER R
GEORGII A
HUEBNER K
SCHWARZE EW
Citation: V. Diehl et al., FURTHER CHEMOTHERAPY VERSUS LOW-DOSE INVOLVED-FIELD RADIOTHERAPY AS CONSOLIDATION OF COMPLETE REMISSION AFTER 6 CYCLES OF ALTERNATING CHEMOTHERAPY IN PATIENTS WITH ADVANCED HODGKINS-DISEASE, Annals of oncology, 6(9), 1995, pp. 901-910